IN-VIVO EFFECTS OF LOCAL AND SYSTEMIC PHENCYCLIDINE ON THE EXTRACELLULAR LEVELS OF CATECHOLAMINES AND TRANSMITTER AMINO-ACIDS IN THE DORSOLATERAL STRIATUM OF ANESTHETIZED RATS

被引:31
作者
LILLRANK, SM [1 ]
OCONNOR, WT [1 ]
SARANSAARI, P [1 ]
UNGERSTEDT, U [1 ]
机构
[1] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM,SWEDEN
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 1994年 / 150卷 / 02期
关键词
ASPARTATE; DOPAMINE; GABA; GLUTAMATE; 5-HIAA; MICRODIALYSIS; PHENCYCLIDINE; SCHIZOPHRENIA;
D O I
10.1111/j.1748-1716.1994.tb09667.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The dose-dependent effects of systemically and locally administered phencyclidine (PCP) on the extracellular levels of dopamine, dihydroxyphenylacetate (DOPAC), homovanillate (HVA), 5-hydroxyindolacetate (5-HIAA), gamma-aminobutyrate (GABA), glutamate and aspartate in the dorsolateral striatum of anaesthetized rats were studied by in vivo microdialysis. Both local(l, 5, 50 and 100 mu M) and systemic (2 and 10 mg kg(-l) i.p.) PCP caused a dose-dependent increase in the extracellular levels of dopamine. The lowest PCP doses caused only a moderate but long-lasting increase in the extracellular levels of dopamine, while the highest PCP doses caused a massive but transient increase followed by a rebound decrease. The low doses of both systemic and local PCP tended to increase the levels of DOPAC, while those of HVA were not changed. The extracellular levels of 5-HIAA were increased only by the lowest (1 mu M) locally administered dose of PCP. GABA levels were increased when PCP was administered locally at two doses. None of the treatments affected the extracellular levels of glutamate and aspartate. The results show that the effects of local and systemic PCP administration are dissimilar on the extracellular levels of 5-HIAA and GABA and thus provide new information on the neurochemical effects of PCP.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 36 条
[1]   PHENCYCLIDINE (PCP) - A REVIEW AND PERSPECTIVES [J].
ANILINE, O ;
PITTS, FN .
CRC CRITICAL REVIEWS IN TOXICOLOGY, 1982, 10 (02) :145-177
[2]  
ARY TE, 1980, LIFE SCI, V26, P575, DOI 10.1016/0024-3205(80)90322-7
[3]   PHENCYCLIDINE-INDUCED RELEASE OF [H-3]DOPAMINE FROM CHOPPED STRIATAL TISSUE [J].
ARY, TE ;
KOMISKEY, HL .
NEUROPHARMACOLOGY, 1982, 21 (07) :639-645
[4]   AMPHETAMINE, COCAINE, PHENCYCLIDINE AND NOMIFENSINE INCREASE EXTRACELLULAR DOPAMINE CONCENTRATIONS PREFERENTIALLY IN THE NUCLEUS ACCUMBENS OF FREELY MOVING RATS [J].
CARBONI, E ;
IMPERATO, A ;
PEREZZANI, L ;
DICHIARA, G .
NEUROSCIENCE, 1989, 28 (03) :653-661
[5]   INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
CARLSSON, M ;
CARLSSON, A .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :272-276
[6]  
CASTELLANI S, 1982, AM J PSYCHIAT, V139, P508
[7]   EFFECTS OF PHENCYCLIDINE ON EXTRACELLULAR LEVELS OF DOPAMINE, DIHYDROXYPHENYLACETIC ACID AND HOMOVANILLIC-ACID IN CONSCIOUS AND ANESTHETIZED RATS [J].
CHAPMAN, CD ;
GAZZARA, RA ;
HOWARD, SG .
NEUROPHARMACOLOGY, 1990, 29 (04) :319-325
[8]   PHENCYCLIDINE ANALOGS INHIBIT NMDA-STIMULATED [H-3] GABA RELEASE FROM CULTURED CORTEX NEURONS [J].
DREJER, J ;
HONORE, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 143 (02) :287-290
[9]   CHARACTERIZATION OF GAMMA-AMINOBUTYRIC ACID AND DOPAMINE OVERFLOW FOLLOWING ACUTE IMPLANTATION OF A MICRODIALYSIS PROBE [J].
DREW, KL ;
OCONNOR, WT ;
KEHR, J ;
UNGERSTEDT, U .
LIFE SCIENCES, 1989, 45 (14) :1307-1317
[10]   THE EFFECTS OF PHENCYCLIDINE AND N-ALLYLNORMETAZOCINE ON MIDBRAIN DOPAMINE NEURONAL-ACTIVITY [J].
FREEMAN, AS ;
BUNNEY, BS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 104 (3-4) :287-293